Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...
The Aligning Science Across Parkinson’s (ASAP) initiative opened applications for members of the research community to apply to join the Collaborative Research Network (CRN) 2025 Scientific Track. The ...
AskBio begins patient randomizing in phase II gene therapy trial for Parkinson’s disease: Berlin, Germany Wednesday, January 15, 2025, 14:00 Hrs [IST] AskBio Inc. (AskBio), a ge ...
The UPV/EHU's Neurochemistry and Neurodegeneration group has come up with a drug that is a potential candidate for tackling ...
A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...
Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...
Chronos-PD’ is looking for biological signals that could indicate increased chance of developing Parkinson’s disease (PD) years before symptoms ...
3dOpinion
Parkinson's disease is a solvable problem, but only if we act decisively and urgently. We have the knowledge, and we've built ...
Hosted on MSN3d
New study shows which dreams can be an early tell-tale sign of dementia or Parkinson's diseaseStudies have consistently indicated that individuals with REM sleep behavior disorder (RBD), who physically act out their ...
Learn how caffeine affects Parkinson's disease prevention and treatment. New research uncovers both protective benefits and treatment limitations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback